(MENAFN- Baystreet) Yum Brands Misses Estimates
Promising Outlook as Biotech Sector Advances Cancer Treatments Amidst Rising Diagnoses
CVS Tumbles on Q1 Figures
Securing America's Future: New Investments Aim to Reduce Dependency on Imported Critical Minerals
Shares Of Starbucks Drop 13% On Earnings Miss And Weak Outlook Previous Articles Subscribe to Get Small Cap News & Alerts Glenn Wilkins - Wednesday, May 1, 2024
AstraZeneca Jumps Ahead of Showing New Data
AstraZeneca (NASDAQLAZN) will showcase new clinical and real-world data across its leading inhaled, biologic and early science respiratory portfolio at the American Thoracic Society (ATS) International Conference, in San Diego from May 17 – 22. The company will present 59 abstracts, including 12 late-breaking posters, with a focus on unmet needs in chronic obstructive pulmonary disease (COPD), severe asthma and eosinophilic granulomatosis with polyangiitis (EGPA), as well as other chronic respiratory diseases.
Executive Vice President Sharon Barr said:“Data at ATS demonstrate our progress in advancing a new wave of innovative treatments, moving beyond symptom control into disease modification, remission and one day, cure. Today, COPD patients have highly limited options if their disease is uncontrolled on inhaled medicines. We're encouraged by the results of the COURSE Phase IIa data exploring tezepelumab in a broad population of COPD patients beyond those with baseline blood eosinophils above 300 cells/μL and look forward to these data being presented at the ATS International Conference.”
Among the highlights of the presentation: leading transformation in COPD care by investigating novel biologic medicines, targeting key drivers across a broad range of patients including: TEZSPIRE® (tezepelumab) beyond severe asthma targeting thymic stromal lymphopoietin (TSLP) and tozorakimab, to reduce excess inflammation and epithelial remodeling in IL-33 driven disease.
AZN shares began Wednesday better by 35 cents to $76.23.
About Us Contact Us Advertise License Our Content Jobs Disclaimer Privacy Policy
Copyright 1998 - 2024 Baystreet Media Corp. All rights reserved. Nasdaq Stocks: Information delayed 15 minutes. Non-Nasdaq Stocks: Information delayed 20 minutes. Bid and Ask quotation information for NYSE and AMEX securities is only available on a real time basis. Market Data is provided by QuoteMedia. Earnings by Zacks. Analyst Ratings by Zacks
MENAFN01052024000212011056ID1108161771
Legal Disclaimer:
MENAFN provides the information “as is” without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the provider above.